Lynn A. Tetrault, Director of Rhythm Pharmaceuticals RYTM, has filed 1 purchase and 11 sales on the open market. Over the past 12 months that comes to a net sale of $3.8M. The latest trade was on 06/24.

LT

LT

Lynn A. Tetrault

Director

Company

Rhythm Pharmaceuticals RYTM

First filing

23/05/24

Trades

59 trades

Buys / sales

1 / 11

12-month net buying

−$3.8M

Last trade

06/24

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Rhythm PharmaceuticalsRYTM	Open-market sale10b5-1 plan	06/22	06/24	37,000 sh	$100.32	$3,711,840	−84.1%
NeogenomicsNEO	Open-market sale10b5-1 plan	06/15	06/17	5,307 sh	$11.10	$58,907.7	−5.8%
NeogenomicsNEO	Open-market sale10b5-1 plan	06/09	06/11	5,307 sh	$11.29	$59,916.03	−5.5%
NeogenomicsNEO	Open-market buy	25/05/09	25/05/09	7,000 sh	$8.14	$56,980	No record
Rhythm PharmaceuticalsRYTM	Open-market sale10b5-1 plan	24/09/09–24/09/10	24/09/11	20,700 sh4 trades	$49.71avg.	$1,029,004.66	−87.3%
Rhythm PharmaceuticalsRYTM	Open-market sale10b5-1 plan	24/08/26	24/08/28	4,300 sh	$50.01	$215,043	−58.9%
Rhythm PharmaceuticalsRYTM	Open-market sale10b5-1 plan	24/08/12	24/08/14	10,000 sh2 trades	$44.65avg.	$446,505.25	−76.9%
NeogenomicsNEO	Open-market sale10b5-1 plan	24/03/04	24/03/06	6,112 sh	$15.97	$97,608.64	−10.9%